For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn’t always provide accurate results, and it exposes women to X-rays. In a study appearing in ACS’ journal MolecularPharmaceutics, scientists report that they have developed a non-invasive “disease screening pill” that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation.
Breast cancer is the second most common cancer in women, according to the American Cancer Society. Mammograms are X-rays of breast tissue that can provide information about a lump’s location and size, but they can’t distinguish between cancerous and benign growths. As a result, up to one in three healthy women undergo unnecessary breast cancer treatments and procedures, according to a recent study by researchers in Denmark. Mammograms also require low levels of radiation. While risk of harm from this exposure is minimal, repeated X-rays can potentially cause health issues. Fluorescent probes can detect breast tumors, but they must be given intravenously. So, Greg M. Thurber and colleagues set out to develop a more accurate, safer technique that was also non-invasive.
The researchers combined two types of molecules into a single pill: a targeting molecule that binds to proteins on the surface of breast cancer cells; and a dye that had negatively charged sulfate groups attached to it. Sulfate groups enhance the solubility of near-infrared florescent dyes, increasing the likelihood of detecting the tumor. Testing in mice showed that with this formulation, a considerable proportion of the imaging agent was absorbed into the bloodstream. It also bound specifically to cancer cells with little background noise. The researchers say that the pill could lead to an accurate, safe and noninvasive way to detect breast cancer, and it could be modified in the future to detect other diseases.
Learn more: Diagnosing breast cancer with an imaging pill
The Latest on: Imaging pill
via Google News
The Latest on: Imaging pill
- BioWorld MedTech Patent Highlights: Week 8on February 27, 2020 at 4:11 pm
An ingestible pill comprising an enteric coating, a medication and a medication-delivery device ... wherein the generated ultrasonic waves comprising a first pulse to deliver imaging or therapeutic ...
- Imaging Scans May Lead to Shorter TB Treatmenton February 27, 2020 at 1:56 pm
THURSDAY, Feb. 27, 2020 (HealthDay News) -- A new monitoring approach could help improve treatment of patients with tuberculosis (TB), researchers say. TB is an infectious disease that primarily ...
- Monitoring Smart Pill Market is Maximizing Efficiency with Top Key Players CapsoVision, Given Imaging, Medimetrics S.A, Olympus Corporationon February 27, 2020 at 3:47 am
An analysis of Global Monitoring Smart Pill Market has been provided within the latest report launched by Big Market Research that primarily focuses on the market trends, demand spectrum, and future ...
- Drug-delivery Smart Pill Market Innovative Solutions By Top Key Players CapsoVision, Given Imaging, Medimetrics S.A, Olympus Corporationon February 27, 2020 at 3:45 am
An analysis of Global Drug-delivery Smart Pill Market has been provided within the latest report launched by Big Market Research that primarily focuses on the market trends, demand spectrum, and ...
- Houston Methodist's new TMC tech hub tests VR, voice-enabled devices and moreon February 27, 2020 at 3:23 am
Houston Methodist, one of the city's largest health systems, opened a hub in its Texas Medical Center hospital to pilot innovative technology.
- Ingestible Smart Pills Market to Gain Proceeds Worth USD 1,147.6 Million by 2022on February 27, 2020 at 2:30 am
Check-Cap Ltd, Chongqing Jinshan Science and Component (Group) Co., Ltd., Given Imaging Ltd., IntroMedic Co., Ltd., Medimetrics, Olympus Corporation, Philips Respironics, Proteus Digital HealthInc.
- HP announces share buyback program to thwart Xerox takeover attempton February 24, 2020 at 5:27 pm
“Plus, Xerox’s copier portfolio, especially its enterprise-focused systems, could complement and fill out HP’s printing and imaging business. Finally, HP is considerably larger than Xerox ...
- A Patient's Guide to Hepatitis Con February 24, 2020 at 3:10 pm
Lee says imaging tests are also used to screen for liver cancer ... Gone are the cumbersome interferon injections, and we now have oral pill therapy, which can achieve a near 97% cure rate." These new ...
- HP, Fuji Xerox and Ricoh back initiative for printer security standardson February 23, 2020 at 8:05 pm
Tuan Tran, president of HP’s imaging, printing and solutions business, said he believes more should be done to mitigate security risks. Read more Xerox ploughs ahead with takeover bid despite HP's ...
via Bing News